Viridian Therapeutics Inc Sustainability Reports
Viridian Therapeutics, Inc. is a biotechnology company focused on developing and commercializing treatments for serious and rare diseases. Its pipeline includes therapies for autoimmune conditions such as thyroid eye disease.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300C775BNYF550E70
FIGI: BBG002H24301
1 reports from 2022 to 2022